A Study Comparing BL-B01D1 With Physician's Choice of Chemotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma(PANKU-NPC01)
Sichuan Baili Pharmaceutical Co., Ltd.
Sichuan Baili Pharmaceutical Co., Ltd.
Bristol-Myers Squibb
DualityBio Inc.
Shanghai Miracogen Inc.
Shanghai Miracogen Inc.
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
DEKA Biosciences
Shanghai JMT-Bio Inc.
ImmunityBio, Inc.
MediLink Therapeutics (Suzhou) Co., Ltd.
Cyteir Therapeutics, Inc.
Merck Sharp & Dohme LLC
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Genzada Pharmaceuticals USA, Inc.
Eisai Inc.
MultiVir, Inc.
Hoffmann-La Roche
Hoffmann-La Roche